It is time to rethink randomized clinical trial approaches

Oncologist. 2024 Sep 6;29(9):e1235-e1236. doi: 10.1093/oncolo/oyae172.

Abstract

This letter to the editor comments on the recently published editorial by Fojo, LaRose, and Bates, and agrees that changes are needed in clinical research approaches.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Neoplasms / therapy
  • Randomized Controlled Trials as Topic*